Work

Phase I Study of Ipilimumab (Neutralizing Monoclonal Anti-CTLA4 Antibody) To Treat Relapse of Malignancy after Allogeneic Hematopoietic Stem Cell Transplantation: Evidence of Tumor Regression without Induction of GVHD.

Year: 2006

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v108.11.410.410

Authors: Asad Bashey, Bridget Medina, Sue Corringham, Mildred Pasek, Ewa Carrier, Howard Streicher, Israel Lowy, James R. Mason, Robert J. Soiffer, Edward D. Ball

Institutions: Northside Hospital, University of California San Diego, Moores Cancer Center, Dana-Farber Cancer Institute, National Cancer Institute, Scripps Clinic

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980895587

FWCI: 0.399

Cites:

Cited by: 2

Related to: 10